Literature DB >> 2431906

Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel.

J Striessnig, K Moosburger, A Goll, D R Ferry, H Glossmann.   

Abstract

The voltage-dependent calcium channel from guinea-pig skeletal muscle T-tubules has been isolated with a rapid, two-step purification procedure. Reversible postlabelling of the channel-linked 1,4-dihydropyridine receptor and stereoselective photolabelling as a novel approach were employed to assess purity. A 135-fold purification to a specific activity of 1311 +/- 194 pmol/mg protein (determined by reversible equilibrium binding with (+)-[3H]PN200-110) was achieved. Three polypeptides of 155 kDa, 65 kDa and 32 kDa were identified in the purified preparation. The 155-kDa band is a glycoprotein. The arylazide photoaffinity probe (-)-[3H]azidopine bound with high affinity to solubilized membranes (Kd = 0.7 +/- 0.2 nM) and highly purified fractions (Kd = 3.1 +/- 2 nM), whereas the optical antipode (+)-azidopine was of much lower affinity. Irradiation of (-)-[3H]azidopine and (+)-[3H]azidopine receptor complexes with ultraviolet light led to preferential incorporation of the (-) enantiomer into the 155-kDa polypeptide in crude solubilized and purified preparations. The pharmacological profile of irreversible labelling of the 155-kDa glycoprotein by (-)-[3H]azidopine is identical to that found in reversible binding experiments. Specific photolabelling of the 155-kDa band by (-)-[3H]azidopine per milligram of protein increases 150-fold upon purification, whereas incorporation into non-specific bands in the crude solubilized material is identical for both, (-) and (+)-[3H]azidopine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431906     DOI: 10.1111/j.1432-1033.1986.tb10484.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.

Authors:  J Striessnig; B J Murphy; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle.

Authors:  M Takahashi; M J Seagar; J F Jones; B F Reber; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers.

Authors:  L Hymel; J Striessnig; H Glossmann; H Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 4.  Calcium channels: molecular pharmacology, structure and regulation.

Authors:  M M Hosey; M Lazdunski
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

5.  PAF activation of a voltage-gated R-type Ca2+ channel in human and canine aortic endothelial cells.

Authors:  G Bkaily; P d'Orléans-Juste; R Naik; J Pérodin; J Stankova; E Abdulnour; M Rola-Pleszczynski
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

6.  Internal and external effects of dihydropyridines in the calcium channel of skeletal muscle.

Authors:  H H Valdivia; R Coronado
Journal:  J Gen Physiol       Date:  1990-01       Impact factor: 4.086

7.  The purified Ca2+ antagonist receptor from skeletal muscle: subunit structure, photoaffinity labeling and endogenous protein kinase activity.

Authors:  B S Tuana; B J Murphy; Q Yi
Journal:  Mol Cell Biochem       Date:  1988 Mar-Apr       Impact factor: 3.396

8.  Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.

Authors:  J Striessnig; H G Knaus; H Glossmann
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

9.  [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.

Authors:  A Grassegger; J Striessnig; M Weiler; H G Knaus; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

10.  A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney.

Authors:  G Zernig; H Glossmann
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.